tiprankstipranks
Trending News
More News >

Genmab price target lowered to DKK 1,500 from DKK 1,700 at JPMorgan

JPMorgan lowered the firm’s price target on Genmab (GMAB) to DKK 1,500 from DKK 1,700 and keeps a Neutral rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue